Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- R&D NEWS IN BRIEF
October 29, 2007
- SEMINAR／Generics to Obtain 1/3 of Market for Antibacterials in 2016: Datamonitor
October 29, 2007
- Korosho to Increase Multinational Joint Trial Participation Rate under 5-Year Plan
October 29, 2007
- Consumption of EPO Decreased in 40% of Patients
October 29, 2007
- OHARA Pharm. Strengthens Product, Information Supply Systems
October 29, 2007
- Merck Ties UP with ImClone, BMS for Erbitux in Japan
October 29, 2007
- JGPMA Announces Goals to Promote Use of Generics
October 29, 2007
- Shionogi's Doripenem Debuts in US Market
October 29, 2007
- SURVEY／Analysis of Medical Bills Show Increases in Use of Generics: Korosho
October 29, 2007
- Infection-related Test Market for 2006 Reaches ¥82.5 Bil.: Fuji Keizai
October 29, 2007
- Action Program Issued by Korosho to Promote Use of Generics
October 29, 2007
- Kirin Pharma to Merge with Kyowa Hakko
October 29, 2007
- Korosho Presents List of Issues to Promote Use of Generics to Chuikyo
October 29, 2007
- More M&As Expected in Japanese Pharma Industry: Mr Eiki
October 29, 2007
- REGULATORY NEW IN BRIEF
October 22, 2007
- Nipro Licenses Double-Bag Kit Product to CWP in South Korea
October 22, 2007
- Main Price Survey to Target Transactions Made in September
October 22, 2007
- MEDRx Developing Products Using its Innovative DDS Technology
October 22, 2007
- Business Owners"Burden Is Lighter in Japan than in Other Countries: Mr Hara
October 22, 2007
- Sanofi-aventis Aims at 31 Submissions by the End of 2010
October 22, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…